|
Market Cap (5-Jun) $19,084,808 (1,108th) |
Close (30-Jun) $0.042 |
Volume (30-Jun) 149,220 |
Shortsold (10-Feb) 15,546 (0.00%) (581st) |
|
52w High $0.059 |
52w Low $0.033 |
P/E 15.29 |
EPS 0 |
RHT released this announcement to the ASX on 30 September 2021, 8:01. The announcement is not marked as price sensitive, and is 61 page(s) in length and 1.76MB in size.
You can view all announcements from RHT and see how they appear on a price chart on the announcements page.
At the date of this announcement, RHT was 0.003% short sold according to ASIC data. It was ranked the 581st most shorted stock on the ASX. It remains ranked 581st as of the latest reported data (10 February 2025).
| Other Recent Announcements from RHT | |
|---|---|
| Receipt of R&D Tax Incentive Refund | 30 June 2023, 12:22 |
| Updated HepaFatSmart Cleared by US FDA | 29 June 2023, 11:04 |
| Management Transition | 23 June 2023, 8:18 |
| Annual Report to shareholders | 30 September 2021, 8:01 |
| Change in substantial holding | 28 September 2021, 14:19 |
| R&D Molecular Medicine ASON Project Results of Dosing Study | 21 September 2021, 15:23 |
| Preliminary Final Report | 30 August 2021, 8:12 |
You must be logged in to post a reply.
Resonance Health 